Synonyms: K 12148 | K12.148 | U-83860
Compound class:
Synthetic organic
Comment: Lifibrol is a model compound being investigated in the development of novel pharmacotherapies for dyslipidaemia [1]. The compoound appears to be a cholesterol synthesis inhibitor.
The INN document for lifibrol specifies that it is a racemic mixture of two enatiomers. We do not specify stereochemistry in our structure therefore this entry represents the mixture. |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-[4-(4-tert-butylphenyl)-2-hydroxybutoxy]benzoic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
6470 | lifibrol |
Synonyms ![]() |
K 12148 | K12.148 | U-83860 |
Database Links ![]() |
|
CAS Registry No. | 96609-16-4 (source: Scifinder) |
ChEMBL Ligand | CHEMBL2105019 |
GtoPdb PubChem SID | 178102509 |
PubChem CID | 57112 |
Search Google for chemical match using the InChIKey | LNXBEIZREVRNTF-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | LNXBEIZREVRNTF |
Search PubMed clinical trials | lifibrol |
Search PubMed titles | lifibrol |
Search PubMed titles/abstracts | lifibrol |
UniChem Compound Search for chemical match using the InChIKey | LNXBEIZREVRNTF-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | LNXBEIZREVRNTF-UHFFFAOYSA-N |